- Home
- TK vs STOK Comparison
TK vs STOK Comparison
Compare TK & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TK
- STOK
- Stock Information
- Founded
- TK 1973
- STOK 2014
- Country
- TK Bermuda
- STOK United States
- Employees
- TK N/A
- STOK N/A
- Industry
- TK Marine Transportation
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- TK Consumer Discretionary
- STOK Health Care
- Exchange
- TK Nasdaq
- STOK Nasdaq
- Market Cap
- TK 554.2M
- STOK 556.7M
- IPO Year
- TK 1995
- STOK 2019
- Fundamental
- Price
- TK $6.68
- STOK $7.21
- Analyst Decision
- TK
- STOK Strong Buy
- Analyst Count
- TK 0
- STOK 8
- Target Price
- TK N/A
- STOK $23.83
- AVG Volume (30 Days)
- TK 706.4K
- STOK 868.5K
- Earning Date
- TK 05-08-2025
- STOK 03-18-2025
- Dividend Yield
- TK N/A
- STOK N/A
- EPS Growth
- TK N/A
- STOK N/A
- EPS
- TK 1.42
- STOK N/A
- Revenue
- TK $1,220,374,000.00
- STOK $36,555,000.00
- Revenue This Year
- TK N/A
- STOK N/A
- Revenue Next Year
- TK N/A
- STOK N/A
- P/E Ratio
- TK $4.69
- STOK N/A
- Revenue Growth
- TK N/A
- STOK 316.34
- 52 Week Low
- TK $5.98
- STOK $7.06
- 52 Week High
- TK $9.95
- STOK $17.58
- Technical
- Relative Strength Index (RSI)
- TK 49.83
- STOK 34.49
- Support Level
- TK $6.55
- STOK $7.18
- Resistance Level
- TK $6.75
- STOK $8.45
- Average True Range (ATR)
- TK 0.20
- STOK 0.60
- MACD
- TK 0.03
- STOK -0.04
- Stochastic Oscillator
- TK 64.53
- STOK 7.59
About TK Teekay Corporation
Teekay Corp Ltd is engaged in providing international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services, and conventional tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.